Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy Study of CPC634 (CriPec® Docetaxel) in Platinum Resistant Ovarian Cancer (CINOVA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03742713
Recruitment Status : Completed
First Posted : November 15, 2018
Last Update Posted : December 28, 2020
Sponsor:
Information provided by (Responsible Party):
Cristal Therapeutics

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 1, 2020
Actual Study Completion Date : December 1, 2020